No Detail Found!

β-Amyrin ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress in mice

Author(s)
Zhiyong Cai Newborn Department, Yancheng Maternity and Child Health Care Hospital,Yancheng, Jiangsu Province,China
Jindi Liu Newborn Department, Yancheng Maternity and Child Health Care Hospital,Yancheng, Jiangsu Province,China
Hongliang Bian Newborn Department, Yancheng Maternity and Child Health Care Hospital,Yancheng, Jiangsu Province,China
Jinlan Cai Newborn Department, Yancheng Maternity and Child Health Care Hospital,Yancheng, Jiangsu Province,China
Abstract
The study aimed to determine efficacy and mechanisms of ß-Amyrin on pulmonary fibrosis. Use bleomycin (BLM) to induce the marine model of pulmonary fibrosis. ß-Amyrin (20, 40, 80 mg/kg) was once treated via intragastrical administration for five consecutive days when after BLM stimulation. HE/Masson staining, hydroxyproline (HYP) content, Arterial blood gas analysis (BGA), inflammatory cytokines and oxidative stress factors were performed in this study. The lung gas-exchange function was significantly improved after being treated ß-Amyrin with different concentrations, while IL-6, IL-1ß, TNF-a and MCP-1 levels were decreased. And the increased fibrotic lesion in lung was also determined after treatment of ß-Amyrin. Additionally, reduced MDA level and increase levels of GPX, SOD and GSH were also demonstrated using ß-Amyrin in BLM-induced mice in a dose-dependent manner. In conclusions, our study determined that ß-Amyrin has a potent efficacy in protecting against BLM-induced pulmonary fibrosis via suppressing inflammatory response and oxidative stress.
Publication Details
Page(s) 431-436
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Oxidative stress, inflammation, Pulmonary fibrosis, ß-Amyrin
0

Citations

0

Downloads

220

Views